Cingulate CINGW
NASDAQ CINGW
$0.01 +0.00 (+4.29%)
As of: Sep 9, 2026 · 11:16 AM EDT

Cingulate (CINGW) Capital Expenditures (2021 - 2025)

Cingulate's (CINGW) quarterly Capital Expenditures came in at $156213.0 in Q4 2025, down 21.29% on a YoY basis from $198462.0 in Q4 2024, and down 21.29% quarter-over-quarter from $198462.0 in Q4 2024.

Analysis

Cingulate (CINGW) Capital Expenditures (2021 - 2025) Analysis & Trends

Cingulate (CINGW) has reported Capital Expenditures for 5 consecutive years, with $156213.0 the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Capital Expenditures fell 21.29% year-over-year to $156213.0; the trailing twelve-month figure through Dec 2025 stood at $147643.0 (down 30.29% YoY), and the FY2025 full-year result was $162138.0, down 23.45% from the prior year.
  • Capital Expenditures fell to $156213.0 in Q4 2025 per CINGW's latest filing, from $198462.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $710007.0 in Q4 2021 and bottomed at -$207032.0 in Q3 2024.
  • Historically, Capital Expenditures has averaged $111447.5 across 5 years, with a median of $73988.5 in 2021.
  • The sharpest annual moves came in 2022 and 2024: Capital Expenditures slumped 84.35% in 2022, then surged 13886100.0% in 2024.
  • Over 5 years, Capital Expenditures stood at $710007.0 in 2021, then tumbled by 79.86% to $143020.0 in 2022, then jumped by 30.72% to $186960.0 in 2023, then gained by 6.15% to $198462.0 in 2024, then declined by 21.29% to $156213.0 in 2025.
  • According to Business Quant data, Capital Expenditures over the past three periods registered $156213.0, $198462.0, and -$207032.0 for Q4 2025, Q4 2024, and Q3 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Johnson & Johnson 644.46 Bn 623.70 Bn 17.26 Bn 1.32 Bn
2 AbbVie 440.11 Bn 433.54 Bn 12.70 Bn 322.00 Mn
3 Merck 365.04 Bn 357.90 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 266.82 Bn 259.13 Bn 11.24 Bn -321.00 Mn
5 Pfizer 159.14 Bn 147.45 Bn 10.94 Bn 533.00 Mn
6 Sanofi 52.47 Bn 45.09 Bn 10.79 Bn -
7 Revolution Medicines 44.26 Bn 44.26 Bn - 2.29 Mn
8 Incyte 25.32 Bn 20.79 Bn 1.57 Bn 12.41 Mn
9 United Therapeutics 21.46 Bn 18.80 Bn 683.80 Mn 108.00 Mn
10 Cingulate 100,214.03 100,214.03 - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 156,213.00
Dec 31, 2024 198,462.00
Sep 30, 2024 -207,032.00
Jun 30, 2024 138,862.00
Mar 31, 2024 81,508.00
Dec 31, 2023 186,960.00
Jun 30, 2023 1.00
Mar 31, 2023 37,135.00
Dec 31, 2022 143,020.00
Mar 31, 2022 10,400.00
Dec 31, 2021 710,007.00
Sep 30, 2021 15,774.00
Jun 30, 2021 22,486.00
Mar 31, 2021 66,469.00